Ads
related to: drugs, brain development
Search results
Neurophet to participate BIO USA… exploring global partnership and business
ThePress.net· 7 days agoNeurophet's imaging CRO service provides analysis of medical images, including MRI and PET scans...
Jacksonville community advocate: New hemp regulation will protect Florida’s children
The Florida Times-Union via Yahoo News· 5 days agoUnfortunately, that isn’t the case. The U.S. Food and Drug Administration has named Delta-8 a...
FDA grants RMAT status for BlueRock’s Parkinson’s therapy
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe RMAT designation is managed by the FDA's Center for Biologics, Evaluation...therapies, aimed at...
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
GuruFocus.com via Yahoo Finance· 3 days agoThese scale advantages extend beyond production and development to include sales and marketing...
Webinar addresses coping with chemo brain
The Times of Northwest Indiana· 19 hours agoFranciscan Health plans to offer the public a free webinar on chemo brain.
CNS Pharmaceuticals (NASDAQ: CNSP) Announces Reverse Stock Split
Digital Journal· 3 days agoPharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain< ...
Understanding Brain Aneurysms: Symptoms and Advanced Treatment Options
CBS News· 3 days agoA brain aneurysm is a potentially life-threatening condition characterized by a weakened or...
New report reveals concerning levels of contaminant found in products of several popular olive oil...
The Cool Down via Yahoo News· 2 days agoA study...similar issues in wildlife, including hormone disruption, and cause problems with...
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 3 days agoMost famously, it causes phocomelia, a disorder that prevents the growth of arms and legs in utero,...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoInnovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 SAN FRANCISCO, U.S. and